17 January 2020

Dermatology Radboudumc and Dermatology Ghent received a grant of 1.6 million euros for investigating dose reduction of the newest biologics for psoriasis.

The BeNeFIT (Belgium-Netherlands Funding of International Trials) program, in which ZonMw and the Belgian KCE have joined forces, has honored the first two grant applications. One of these is a study into the dose reduction of biologics in psoriasis, carried out by Elke de Jong and Juul van den Reek and UZ Gent, Jo Lambert and Lynda Grine. Reduction of new generation biologics in psoriasis. This awarded project concerns research into dose reduction of new generation biologics in psoriasis. Biologics are very effective agents for the treatment of psoriasis. Previous research has shown that the dose of TNFα-blocking biologics can be reduced in some patients. For the new generation of biologics, IL17 and IL23 inhibitors, it is not yet known whether dose reduction of these agents is possible. The new agents have different mechanisms and safety profiles in comparison with TNFα blockers and are increasingly prescribed. It is therefore important to investigate the possibilities for dose reduction of these new biologics in a timely manner.

ZonMw and KCE granted 1.6 millon euros to perform this large multinational study in 17 hospitals in Belgium and the Netherlands. 

Related news items


Radboudumc researchers publish new insights into COVID-19 Consequences for treatment are now being examined internationally

10 April 2020

Researchers at the Radboud university medical center seem to have found an essential mechanism in the disease process of Covid-19, which has so far been overlooked. If the insight is correct, it probably has important consequences for the treatment of the disease.

read more

Stuttering DNA orchestrates the start of the mosquito’s life

9 April 2020

A certain type of junk DNA that is found in mosquitoes and which repeats itself dozens of times, known as ‘satellite DNA’, has now been shown to play an essential role in the early development of mosquito embryos. Ronald van Rij and colleagues published their findings in Nature.  

read more

Webinar for researchers 20 April 17:00 hrs

9 April 2020

The corona crisis has an impact on our research every day. Therefore we organize a webinar specifically aimed at researchers. Do you have specific topics or questions that you would like to see reflected in the webinar? Let us know via research@radboudumc.nl.

read more

Gut microbiota from AD(H)D patients affects mice brain

8 April 2020

In a recent study, published in the journal Microbiota, Radboudumc researchers showed that gut microbiota from AD(H)D patients can cause brain alterations in mice.

read more

The ICI Amsterdam-Leiden-Nijmegen cancer vaccine consortium

7 April 2020

The Chemical Immunology group from Martijn Verdoes, theme Nanomedicine, joined forces with two Organic Chemistry groups and a Chemical Biology group from Leiden University, and Immunology groups at the AmsterdamUMC and the LUMC to form a consortium to develop new cancer vaccines.

read more

Martinus van Marum prize for Tom Schirris

3 April 2020

This award of € 12,500 is intended as an incentive prize for researchers who have obtained their PhD degree in 2015 or later. The jury, consisting of members of the Society, came to this decision unanimously.

read more